4.7 Review

Diet-gut microbiota-epigenetics in metabolic diseases: From mechanisms to therapeutics

Journal

BIOMEDICINE & PHARMACOTHERAPY
Volume 153, Issue -, Pages -

Publisher

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biopha.2022.113290

Keywords

Diet; Epigenetics; Gut microbiota; Microbiota-derived metabolites; Metabolic diseases

Funding

  1. National Natural Science Foundation of China [81202805,82074254]
  2. Beijing Natural Science Foundation [7172185]
  3. Science and Technology Innovation Project of China Academy of Chinese Medical Science [C12021A01413]

Ask authors/readers for more resources

The prevalence of metabolic diseases, such as obesity, type 2 diabetes, and nonalcoholic fatty liver disease, is closely related to environmental factors like diet and gut microbiota, as well as epigenetic modifications. Dietary components and habits can regulate the changes in gut microbiota, while microbiota-derived metabolites may play a role in the regulation of epigenetic modifications. These epigenetic changes mediated by microbial metabolites participate in metabolic disorders through alterations in intestinal permeability, immune responses, inflammatory reactions, and insulin resistance.
The prevalence of metabolic diseases, including obesity, dyslipidemia, type 2 diabetes mellitus (T2DM), and nonalcoholic fatty liver disease (NAFLD), is a severe burden in human society owing to the ensuing high morbidity and mortality. Various factors linked to metabolic disorders, particularly environmental factors (such as diet and gut microbiota) and epigenetic modifications, contribute to the progression of metabolic diseases. Dietary components and habits regulate alterations in gut microbiota; in turn, microbiota-derived metabolites, such as short-chain fatty acids (SCFAs), are influenced by diet. Interestingly, diet-derived microbial metabolites appear to produce substrates and enzymatic regulators for epigenetic modifications (such as DNA methylation, histone modifications, and non-coding RNA expression). Epigenetic changes mediated by microbial metabolites participate in metabolic disorders via alterations in intestinal permeability, immune responses, inflammatory reactions, and insulin resistance. In addition, microbial metabolites can trigger inflammatory immune responses and microbiota dysbiosis by directly binding to G-protein-coupled receptors (GPCRs). Hence, diet-gut microbiota-epigenetics may play a role in metabolic diseases. However, their complex relationships with metabolic diseases remain largely unknown and require further investigation. This review aimed to elaborate on the interactions among diet, gut microbiota, and epigenetics to uncover the mechanisms and therapeutics of metabolic diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available